We have located links that may give you full text access.
Factors determining exercise capacity evaluated during cardiopulmonary exercise testing in 6 months follow up after ST elevation myocardial infarction.
Clinical Physiology and Functional Imaging 2018 December 28
INTRODUCTION: ST elevation myocardial infarction (STEMI) is one of the main causes of congestive heart failure (CHF). The main symptom of CHF is exercise tolerance impairment. The aim of the study was to evaluate the prevalence and risk factors for impaired exercise tolerance in patients after STEMI.
METHODS AND RESULTS: 84 patients with STEMI were analyzed in the study. Cardiopulmonary exercise test (CPET) was performed 6 months after STEMI. Impaired exercise tolerance defined as peak VO2 < 84% predicted for age and sex was present in 49 (58%) patients and was connected with lack of abciximab administration (91,4 vs 69%, p=0·02) and the presence of mitral regurgitation (47 vs. 23%, p=0·02). In univariate analysis the troponin I level at admission (OR 1·89, p=0·047), the use of abciximab (OR 0·21, p=0·03), the presence of mitral regurgitation (OR 2·98, p=0·03) and NT-proBNP concentration (OR 2·17, p=0·021) were related to impaired exercise tolerance. The best multivariate model for predicting impaired exercise tolerance included mitral regurgitation and lack of abciximab administration.
CONCLUSIONS: Impaired exercise tolerance after STEMI is common. Mitral regurgitation and lack of abciximab administration are the best predicting factors of impaired exercise tolerance after STEMI. This article is protected by copyright. All rights reserved.
METHODS AND RESULTS: 84 patients with STEMI were analyzed in the study. Cardiopulmonary exercise test (CPET) was performed 6 months after STEMI. Impaired exercise tolerance defined as peak VO2 < 84% predicted for age and sex was present in 49 (58%) patients and was connected with lack of abciximab administration (91,4 vs 69%, p=0·02) and the presence of mitral regurgitation (47 vs. 23%, p=0·02). In univariate analysis the troponin I level at admission (OR 1·89, p=0·047), the use of abciximab (OR 0·21, p=0·03), the presence of mitral regurgitation (OR 2·98, p=0·03) and NT-proBNP concentration (OR 2·17, p=0·021) were related to impaired exercise tolerance. The best multivariate model for predicting impaired exercise tolerance included mitral regurgitation and lack of abciximab administration.
CONCLUSIONS: Impaired exercise tolerance after STEMI is common. Mitral regurgitation and lack of abciximab administration are the best predicting factors of impaired exercise tolerance after STEMI. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app